Evelo Biosciences, Inc. (EVLO)
OTCMKTS: EVLO · Delayed Price · USD
0.0001
-0.0504 (-99.80%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Evelo Biosciences Market Cap
Evelo Biosciences has a market cap or net worth of $1.90 thousand as of July 22, 2024. Its market cap has decreased by -100.00% in one year.
Market Cap
1.90K
Enterprise Value
16.69M
1-Year Change
-100.00%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since May 9, 2018, Evelo Biosciences's market cap has decreased from $517.90M to $1.90K, a decrease of -100.00%. That is a compound annual growth rate of -89.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2023 | 6.00M | -96.60% |
| Dec 30, 2022 | 176.50M | -45.61% |
| Dec 31, 2021 | 324.50M | -41.89% |
| Dec 31, 2020 | 558.40M | 328.55% |
| Dec 31, 2019 | 130.30M | -68.47% |
| Dec 31, 2018 | 413.30M | -20.20% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |